Published in PLoS Pathog on May 10, 2012
Resurrection of endogenous retroviruses in antibody-deficient mice. Nature (2012) 1.81
HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates. J Clin Invest (2012) 1.14
Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis. Bioessays (2013) 0.98
Endogenous retroviruses and the development of cancer. J Immunol (2014) 0.97
Mice of the resistant H-2(b) haplotype mount broad CD4(+) T cell responses against 9 distinct Friend virus epitopes. Virology (2014) 0.82
Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection. Sci Rep (2016) 0.80
Stepwise B-cell-dependent expansion of T helper clonotypes diversifies the T-cell response. Nat Commun (2016) 0.79
Clonotypic composition of the CD4+ T cell response to a vectored retroviral antigen is determined by its speed. J Immunol (2014) 0.79
Classification and characterization of human endogenous retroviruses; mosaic forms are common. Retrovirology (2016) 0.78
Narrowing the Gap: Preserving Repertoire Diversity Despite Clonal Selection during the CD4 T Cell Response. Front Immunol (2015) 0.77
Infection of adult thymus with murine retrovirus induces virus-specific central tolerance that prevents functional memory CD8+ T cell differentiation. PLoS Pathog (2014) 0.77
Dichotomy between T Cell and B Cell Tolerance to Neonatal Retroviral Infection Permits T Cell Therapy. J Immunol (2016) 0.75
Opposing Development of Cytotoxic and Follicular Helper CD4 T Cells Controlled by the TCF-1-Bcl6 Nexus. Cell Rep (2016) 0.75
Antigenicity of peptides comprising the immunosuppressive domain of the retroviral envelope glycoprotein. Wellcome Open Res (2016) 0.75
Mutation of the Putative Immunosuppressive Domain of the Retroviral Envelope Glycoprotein Compromises Infectivity. J Virol (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
RAG-1-deficient mice have no mature B and T lymphocytes. Cell (1992) 20.97
A whole-genome association study of major determinants for host control of HIV-1. Science (2007) 15.19
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
Sequence analysis of peptides bound to MHC class II molecules. Nature (1991) 5.99
The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol (2009) 5.99
Structure of endogenous murine leukemia virus DNA in mouse genomes. Proc Natl Acad Sci U S A (1980) 4.24
Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection. Nature (2010) 3.57
A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity. Immunity (2003) 3.41
Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol (2006) 3.01
Retrovirus restriction factors. Mol Cell (2004) 2.95
AKR murine leukemia virus genome: frequency of sequences in DNA of high-, low-, and non-virus-yielding mouse strains. Proc Natl Acad Sci U S A (1974) 2.91
Lymphoid development in mice congenitally lacking T cell receptor alpha beta-expressing cells. Science (1992) 2.90
The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J Immunol Methods (1998) 2.78
An endogenous positively selecting peptide enhances mature T cell responses and becomes an autoantigen in the absence of microRNA miR-181a. Nat Immunol (2009) 2.38
Immunity to retroviral infection: the Friend virus model. Proc Natl Acad Sci U S A (1997) 2.28
Immunology and the elusive AIDS vaccine. Nature (2010) 2.26
Heterologous immunity between viruses. Immunol Rev (2010) 2.20
HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control. J Immunol (2010) 2.10
Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection. J Exp Med (2009) 2.03
HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function. J Virol (2010) 1.90
Critical role for CD4(+) T cells in controlling retrovirus replication and spread in persistently infected mice. J Virol (1998) 1.83
Retroviral superinfection resistance. Retrovirology (2005) 1.82
High prevalence of low affinity peptide-MHC II tetramer-negative effectors during polyclonal CD4+ T cell responses. J Exp Med (2011) 1.76
T cell responses to human endogenous retroviruses in HIV-1 infection. PLoS Pathog (2007) 1.70
Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors. J Virol (1996) 1.68
Depletion of CD4⁺ T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques. J Clin Invest (2011) 1.62
On the composition of the preimmune repertoire of T cells specific for Peptide-major histocompatibility complex ligands. Annu Rev Immunol (2010) 1.61
Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells. J Clin Invest (2008) 1.58
Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus. J Virol (2007) 1.50
Differential kinetics of antigen-specific CD4+ and CD8+ T cell responses in the regression of retrovirus-induced sarcomas. J Immunol (2002) 1.46
High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control. J Virol (2011) 1.44
T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. Immunity (1997) 1.40
Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals. AIDS Res Hum Retroviruses (2006) 1.40
Escape from highly effective public CD8+ T-cell clonotypes by HIV. Blood (2011) 1.39
Structural and biophysical determinants of αβ T-cell antigen recognition. Immunology (2012) 1.30
The T cell repertoire in infection and vaccination: implications for control of persistent viruses. Curr Opin Immunol (2007) 1.28
Host genetic factors that control immune responses to retrovirus infections. Vaccine (2008) 1.26
Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev Med Virol (2005) 1.24
Regulation of major histocompatibility complex class II gene expression, genetic variation and disease. Genes Immun (2009) 1.21
Retrovirus-specificity of regulatory T cells is neither present nor required in preventing retrovirus-induced bone marrow immune pathology. Immunity (2008) 1.20
Allelic polymorphism in the T cell receptor and its impact on immune responses. J Exp Med (2010) 1.18
HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity. PLoS Pathog (2010) 1.17
Negative selection imparts peptide specificity to the mature T cell repertoire. Proc Natl Acad Sci U S A (2003) 1.16
HERV-K(HML-2) GAG/ENV antibodies as indicator for therapy effect in patients with germ cell tumors. Int J Cancer (2004) 1.10
Role of natural killer cells in resistance against friend retrovirus-induced leukemia. J Virol (2001) 1.08
Mechanism of interaction between endogenous ecotropic murine leukemia viruses in (BALB/c X C57BL/6) hybrid cells. Virology (1988) 1.06
B lymphocyte activation by coinfection prevents immune control of friend virus infection. J Immunol (2008) 1.06
Fine structure of a virus-encoded helper T-cell epitope expressed on FBL-3 tumor cells. J Virol (1994) 1.06
Race between retroviral spread and CD4+ T-cell response determines the outcome of acute Friend virus infection. J Virol (2009) 1.05
Identification of an epitope encoded in the env gene of Friend murine leukemia virus recognized by anti-Friend virus cytotoxic T lymphocytes. Virology (1991) 1.04
The potential roles of endogenous retroviruses in autoimmunity. Immunol Rev (1996) 1.04
The pathogenic potential of endogenous retroviruses: a sceptical view. Trends Microbiol (1999) 0.99
Mobility and integration sites of a murine C57BL/6 melanoma endogenous retrovirus involved in tumor progression in vivo. Int J Cancer (2006) 0.95
Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE. Autoimmunity (2008) 0.93
Identification of a melanoma marker derived from melanoma-associated endogenous retroviruses. Cancer Res (2006) 0.92
Mechanisms of control of acute Friend virus infection by CD4+ T helper cells and their functional impairment by regulatory T cells. J Gen Virol (2009) 0.91
B cells and TCR avidity determine distinct functions of CD4+ T cells in retroviral infection. J Immunol (2011) 0.90
Role of endogenous retroviruses in murine SLE. Autoimmun Rev (2010) 0.87
Polymorphism within a TCRAV family influences the repertoire through class I/II restriction. J Immunol (1998) 0.86
Epitope specificity and relative clonal abundance do not affect CD8 differentiation patterns during lymphocytic choriomeningitis virus infection. J Virol (2009) 0.83
Cytotoxic T lymphocytes to endogenous mouse retroviruses and mechanisms of retroviral escape. Immunol Rev (1999) 0.83
Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo. J Immunol (1998) 0.82
Endogenous retroviral envelope antigens recognized by B lymphocytes during graft-versus-host reaction. Tohoku J Exp Med (1994) 0.77
Onset and progression in inherited ALS determined by motor neurons and microglia. Science (2006) 9.42
Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci U S A (2004) 5.31
HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature (2011) 5.28
A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction. Curr Biol (2005) 5.24
TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol (2005) 4.89
Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology (2010) 4.18
A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc Natl Acad Sci U S A (2004) 4.06
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest (2005) 3.08
High-resolution structure of a retroviral capsid hexameric amino-terminal domain. Nature (2004) 2.84
Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. PLoS Genet (2007) 2.33
All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction. J Virol (2006) 2.26
T cell regulation as a side effect of homeostasis and competition. J Exp Med (2003) 2.15
CD4+ memory T cells: functional differentiation and homeostasis. Immunol Rev (2006) 1.84
Resurrection of endogenous retroviruses in antibody-deficient mice. Nature (2012) 1.81
Tripartite-motif proteins and innate immune regulation. Curr Opin Immunol (2010) 1.73
Type I interferon-dependent and -independent expression of tripartite motif proteins in immune cells. Eur J Immunol (2008) 1.67
Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle. J Virol (2006) 1.66
Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome. J Virol (2008) 1.62
The design of artificial retroviral restriction factors. Virology (2007) 1.51
TRIM5 alpha cytoplasmic bodies are highly dynamic structures. Mol Biol Cell (2007) 1.47
PCR master mixes harbour murine DNA sequences. Caveat emptor! PLoS One (2011) 1.41
Virology. A new virus for old diseases? Science (2009) 1.38
Retroviral capsid determinants of Fv1 NB and NR tropism. J Virol (2004) 1.35
Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis. J Immunol (2005) 1.34
Homeostasis and T cell regulation. Curr Opin Immunol (2004) 1.26
Novel escape mutants suggest an extensive TRIM5α binding site spanning the entire outer surface of the murine leukemia virus capsid protein. PLoS Pathog (2011) 1.24
Generalized immune activation as a direct result of activated CD4+ T cell killing. J Biol (2009) 1.22
Capsid processing requirements for abrogation of Fv1 and Ref1 restriction. J Virol (2005) 1.22
Retrovirus-specificity of regulatory T cells is neither present nor required in preventing retrovirus-induced bone marrow immune pathology. Immunity (2008) 1.20
Restriction of foamy viruses by primate Trim5alpha. J Virol (2008) 1.19
A major role for memory CD4 T cells in the control of lymphopenia-induced proliferation of naive CD4 T cells. J Immunol (2005) 1.17
Structure of B-MLV capsid amino-terminal domain reveals key features of viral tropism, gag assembly and core formation. J Mol Biol (2007) 1.17
Emv2, the only endogenous ecotropic murine leukemia virus of C57BL/6J mice. Retrovirology (2012) 1.15
Structural and functional analysis of prehistoric lentiviruses uncovers an ancient molecular interface. Cell Host Microbe (2010) 1.11
B lymphocyte activation by coinfection prevents immune control of friend virus infection. J Immunol (2008) 1.06
Race between retroviral spread and CD4+ T-cell response determines the outcome of acute Friend virus infection. J Virol (2009) 1.05
Determinants of high titer in recombinant porcine endogenous retroviruses. J Virol (2004) 1.04
Ordered assembly of murine leukemia virus capsid protein on lipid nanotubes directs specific binding by the restriction factor, Fv1. Proc Natl Acad Sci U S A (2011) 1.04
CD4 T-cell memory. Semin Immunol (2004) 1.01
Suppression of innate immune pathology by regulatory T cells during Influenza A virus infection of immunodeficient mice. J Virol (2010) 1.01
Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis. Bioessays (2013) 0.98
Noncognate interaction with MHC class II molecules is essential for maintenance of T cell metabolism to establish optimal memory CD4 T cell function. J Immunol (2007) 0.95
The concept of space and competition in immune regulation. Immunology (2004) 0.95
Structure of the capsid amino-terminal domain from the betaretrovirus, Jaagsiekte sheep retrovirus. J Mol Biol (2008) 0.95
Phenotype and function of myeloid dendritic cells derived from African green monkey blood monocytes. J Immunol Methods (2005) 0.94
Capsid-binding retrovirus restriction factors: discovery, restriction specificity and implications for the development of novel therapeutics. J Gen Virol (2013) 0.93
Mechanisms of control of acute Friend virus infection by CD4+ T helper cells and their functional impairment by regulatory T cells. J Gen Virol (2009) 0.91
Tumor necrosis factor-alpha regulation of insulin-like growth factor-I, type 1 IGF receptor, and IGF binding protein expression in cerebellum of transgenic mice. J Neurosci Res (2003) 0.91
Intracellular localisation of Fv1. Virology (2003) 0.91
B cells and TCR avidity determine distinct functions of CD4+ T cells in retroviral infection. J Immunol (2011) 0.90
A unique spumavirus Gag N-terminal domain with functional properties of orthoretroviral matrix and capsid. PLoS Pathog (2013) 0.90
Mammalian Endogenous Retroviruses. Microbiol Spectr (2015) 0.90
Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model. Retrovirology (2011) 0.89
Characterization of an amino-terminal dimerization domain from retroviral restriction factor Fv1. J Virol (2006) 0.87
Unique spectrum of activity of prosimian TRIM5alpha against exogenous and endogenous retroviruses. J Virol (2011) 0.87
IL-2-independent and TNF-α-dependent expansion of Vβ5+ natural regulatory T cells during retrovirus infection. J Immunol (2013) 0.86
The role of TNF/TNFR in organ-specific and systemic autoimmunity: implications for the design of optimized 'anti-TNF' therapies. Curr Dir Autoimmun (2002) 0.85
Immunization with biodegradable nanoparticles efficiently induces cellular immunity and protects against influenza virus infection. J Immunol (2013) 0.85
Negative impact of IFN-γ on early host immune responses to retroviral infection. J Immunol (2012) 0.85
Counterpoise between the microbiome, host immune activation and pathology. Curr Opin Immunol (2013) 0.83
Consensus structural models for the amino terminal domain of the retrovirus restriction gene Fv1 and the murine leukaemia virus capsid proteins. BMC Struct Biol (2004) 0.83
Virology. Our viral inheritance. Science (2013) 0.81
A comparison of murine leukemia viruses that escape from human and rhesus macaque TRIM5αs. J Virol (2013) 0.80
Binding of more than one Tva800 molecule is required for ASLV-A entry. Retrovirology (2011) 0.79
Apparent effect of rabbit endogenous lentivirus type K acquisition on retrovirus restriction by lagomorph Trim5αs. Philos Trans R Soc Lond B Biol Sci (2013) 0.78
IL10-Deficiency in CD4⁺ T Cells Exacerbates the IFNγ and IL17 Response During Bacteria Induced Colitis. Cell Physiol Biochem (2015) 0.77
Bending out and breaking away: host-cell accomplices in retroviral escape. J Biol (2003) 0.77
TRIM proteins and the innate immune response to viruses. Adv Exp Med Biol (2012) 0.77